A detailed history of Nantahala Capital Management, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 625,659 shares of IMTX stock, worth $4.44 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
625,659
Previous 787,974 20.6%
Holding current value
$4.44 Million
Previous $9.16 Million 22.04%
% of portfolio
0.42%
Previous 0.61%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.93 - $12.92 $1.77 Million - $2.1 Million
-162,315 Reduced 20.6%
625,659 $7.14 Million
Q1 2024

May 15, 2024

SELL
$10.23 - $12.94 $6.4 Million - $8.1 Million
-625,982 Reduced 44.27%
787,974 $8.28 Million
Q4 2023

Feb 14, 2024

SELL
$7.36 - $10.89 $3.73 Million - $5.52 Million
-506,680 Reduced 26.38%
1,413,956 $14.9 Million
Q3 2023

Nov 14, 2023

SELL
$11.01 - $12.62 $4.01 Million - $4.6 Million
-364,259 Reduced 15.94%
1,920,636 $22.2 Million
Q2 2023

Aug 14, 2023

SELL
$5.92 - $12.72 $2.74 Million - $5.9 Million
-463,632 Reduced 16.87%
2,284,895 $26.4 Million
Q4 2022

Feb 14, 2023

BUY
$8.05 - $11.58 $278,199 - $400,193
34,559 Added 1.27%
2,748,527 $23.9 Million
Q3 2022

Nov 10, 2022

SELL
$3.31 - $13.06 $1.35 Million - $5.33 Million
-407,791 Reduced 13.06%
2,713,968 $27.1 Million
Q2 2022

Aug 15, 2022

BUY
$6.0 - $9.37 $1.06 Million - $1.66 Million
177,100 Added 6.01%
3,121,759 $27.2 Million
Q1 2022

May 13, 2022

BUY
$6.64 - $12.85 $172,620 - $334,061
25,997 Added 0.89%
2,944,659 $23.5 Million
Q4 2021

Feb 14, 2022

BUY
$10.81 - $14.38 $2.93 Million - $3.9 Million
271,213 Added 10.24%
2,918,662 $39.2 Million
Q3 2021

Nov 15, 2021

BUY
$11.58 - $15.46 $1.19 Million - $1.59 Million
102,827 Added 4.04%
2,647,449 $34.4 Million
Q2 2021

Aug 16, 2021

BUY
$10.43 - $12.81 $1.07 Million - $1.32 Million
102,857 Added 4.21%
2,544,622 $29.5 Million
Q1 2021

May 14, 2021

SELL
$10.24 - $14.6 $744,693 - $1.06 Million
-72,724 Reduced 2.89%
2,441,765 $27.4 Million
Q4 2020

Feb 16, 2021

SELL
$9.67 - $12.05 $1.04 Million - $1.3 Million
-107,675 Reduced 4.11%
2,514,489 $27.1 Million
Q3 2020

Nov 16, 2020

BUY
$8.73 - $15.15 $22.9 Million - $39.7 Million
2,622,164 New
2,622,164 $27 Million

Others Institutions Holding IMTX

About Immatics N.V.


  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $541M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.